Clinical Trial Update: A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) [Phase 2]

View source ↗

Summary

A Phase 2 study to evaluate the antiviral activity and immune response of AHB-137 injection in participants with chronic hepatitis B; status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137 injection (AHB-137)

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: RECRUITING